According to FutureWise analysis the market for Nephroureteral Stent in 2023 is US$ 2.66 billion, and is expected to reach US$ 4.31 billion by 2031 at a CAGR of 6.22%.
It's a thin tube inserted into the ureter to prevent or treat obstructions of urine flow caused by conditions such as kidney stones, tumors, infections, etc. A nephroureteral stent is a tube placed in the ureter for draining urine from the kidney to the bladder. It is usually 10-12 inches in length. Stents used in adult patients vary in length from 24 to 30 cm, as well as in diameter or gauge, to fit ureters of different sizes. Stents are usually inserted using a cystoscope. A person usually cannot have nephroureteral stents for more than 3 to 6 months. For a longer period of time, there is the possibility of secondary complications like stone formation, urethral infection, etc. that make stent removal difficult. Market players are researching ways to overcome biofilm formation and mineral encrustation.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Nephroureteral Stent Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Nephroureteral Stent Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.